| 刘艳梅,任燕,贾玉龙,姚明宏,邹康,林凯,孙鑫.真实世界数据体系构建的模式探索[J].Chinese journal of Epidemiology,2022,43(3):418-423 |
| 真实世界数据体系构建的模式探索 |
| Exploration of construction mode of real-world data system |
| Received:August 24, 2021 |
| DOI：10.3760/cma.j.cn112338-20210824-00675 |
| KeyWord: 真实世界数据体系 特许医疗 药物和医疗器械临床评价 |
| English Key Word: Real-world data system Licensed medical care Clinical evaluation of drugs and devices |
| FundProject:四川省青年科技创新研究团队（2020JDTD0015）；四川大学华西医院学科卓越发展1·3·5工程项目（ZYYC08003）；国家药品监督管理局“上市后药品的安全性监测和评价方法研究项目”（HX-H2003033）；美国中华医学会基金会项目（CMB19-324）；国家自然科学基金（72004149） |
| Author Name | Affiliation | E-mail | | Liu Yanmei | Chinese Evidence-based Medicine Center and Cochrane China Center, West China Hospital, Sichuan University, Chengdu 610041, China | | | Ren Yan | NMPA Key Laboratory for Real World Data Research and Evaluation in Hainan, Chengdu 610041, China | | | Jia Yulong | Chinese Evidence-based Medicine Center and Cochrane China Center, West China Hospital, Sichuan University, Chengdu 610041, China | | | Yao Minghong | Chinese Evidence-based Medicine Center and Cochrane China Center, West China Hospital, Sichuan University, Chengdu 610041, China | | | Zou Kang | Chinese Evidence-based Medicine Center and Cochrane China Center, West China Hospital, Sichuan University, Chengdu 610041, China | | | Lin Kai | Center for Adverse Drug Reaction Monitoring of Boao Pilot Zone of Hainan province, Haikou 570216, China | 439856605@qq.com | | Sun Xin | Chinese Evidence-based Medicine Center and Cochrane China Center, West China Hospital, Sichuan University, Chengdu 610041, China | sunxin@wchscu.cn |
|
| Hits: 2525 |
| Download times: 820 |
| Abstract: |
| 真实世界数据研究证据作为评价药物和医疗器械（药械）安全性和有效性的重要组成部分，日益受到国内外监管机构和学者的关注，已成为支持药械研发与审评的关键证据来源。本文在真实世界数据的前期实际研究基础上，结合国内外监管机构所发布的指导原则/技术规范和学术研究成果，系统探讨了真实世界数据体系的构建流程和模式探索。以期为特许药械产生满足监管要求的临床评价证据提供参考，而且为研究者、申办方及监管部门顺利开展真实世界数据研究提供借鉴。 |
| English Abstract: |
| Real-world data study evidence, as an important part of evaluating the safety and effectiveness of drugs and devices, has attracted increasing attention from regulatory agencies and scholars both at home and abroad, and has become an essential source of evidence to support the development and review of drugs and devices. This paper systematically discusses the process and mode of real-world data system construction based on the preliminary practical study of real-world data according to the guidelines/technical specifications issued by regulatory agencies and academic research results. This study result provides not only reference for the generation of clinical evaluation evidence to meet the regulatory requirements for innovative drugs and devices, but also reference for researchers, sponsors and regulators to carry out real-world data studies successfully. |
|
View Fulltext
Html FullText
View/Add Comment Download reader |
| Close |
|
|
|